Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Noncoding Self-RNA Implicated in Lupus Development

Bryn Nelson, Ph  |  June 17, 2024

Kathrin Plath, PhD, a professor of biological chemistry, the University of California, Los Angeles, who has studied the role of XIST in initiating and maintaining X chromosome inactivation, says she’s intrigued by the new study. She cautions, however, that more in vivo data will be needed to confirm the role of XIST fragments as important TLR7 ligands. “Overall, [this is] an exciting avenue and it would be amazing if XIST enables female development, but then also causes autoimmunity in females,” Dr. Plath says.

Separate studies are providing independent support for the emerging hypothesis. One recent study in a mouse model of lupus showed that male mice engineered to produce XIST churned out autoantibodies and developed a more severe multi-organ pathology than mice lacking XIST. The finding, the authors report, suggests that complexes formed by XIST and bound proteins act as “antigenic triggers underlying the greater prevalence of autoimmune diseases in females.”6

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

As part of his own lab’s next steps, Dr. Antiochos hopes to understand more about how XIST travels from its initial attachment site on an X chromosome within the cell nucleus to extracellular vesicles in a way that activates TLR7.

“The other big question in my mind that is a direct result of this work is ‘Why is XIST up-regulated in these patients with lupus compared to healthy women?’” Dr. Antiochos says. If interferon doesn’t impact XIST expression in adults, what does? “That’s an area where there’s not a lot that’s understood,” he says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Bryn Nelson, PhD, is a medical journalist based in Seattle.

References

  1. Brown GJ, Cañete PF, Wang H, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022 May; 605(7909):349–356.
  2. Weckerle, CE and Niewold, TM. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immmunol. 2011 Feb; 40(1):42–49.
  3. Crawford JD, Wang H, Trejo-Zambrano D, et al. The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE. JCI Insight. 2023 Oct 23; 8(20):e169344.
  4. Souyris M, Cenac C, Azar P, et al. TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol. 2018 Jan 26;3(19):eaap8855.
  5. Yu B, Qi Y, Li R, et al. B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell. 2021 Apr 1;184(7):1790–1803.e17.
  6. Dou DR, Zhao Y, Belk JA, et al. Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell. 2024 Feb 1;187(3):733–749.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:genetic riskself-RNASLE Resource CenterTLR-7XIST

Related Articles

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    The Type I Interferon Pathway’s Influence in Connective Tissue Disease

    July 18, 2019

    Type I interferon appears to play a role in disease susceptibility and pathogenesis in several classic connective tissue diseases, at least in some patients. Below, I present evidence supporting this connection, explore potential missing links in pathogenesis and discuss biological treatments that target the pathway. The Type I Interferon Pathway Interferons are a class of…

    A&R Abstracts – T CELLS

    August 1, 2011

    For Further Reading

    Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease

    January 1, 2010

    A perspective on B cell–targeted therapies in autoimmune disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences